Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-83,820
Closed -$9.52M 99
2024
Q3
$9.52M Buy
83,820
+3,810
+5% +$453K 1.02% 27
2024
Q2
$9.91M Sell
80,010
-4,654
-5% -$599K 1.02% 23
2024
Q1
$11.2M Sell
84,664
-101,228
-54% -$12.5M 1.13% 21
2023
Q4
$20.3M Sell
185,892
-67,437
-27% -$7M 2.06% 12
2023
Q3
$26.1M Sell
253,329
-676
-0.3% -$72.9K 3.14% 6
2023
Q2
$29.3M Buy
254,005
+307
+0.1% +$34.9K 3.41% 4
2023
Q1
$27M Buy
253,698
+116,420
+85% +$12.6M 3.4% 5
2022
Q4
$15.2M Buy
+137,278
New +$14M 2.05% 16

Other funds holding MRK

Longbow Finance's MRK Position: Q4 2024 in Review

Longbow Finance sold out of Merck (MRK) in Q4 2024, closing a stake of 83,820 shares — an estimated $9.52M sold.

Longbow Finance first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $29.3M in Q2 2023. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Longbow Finance reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Longbow Finance sold 83,820 Merck shares in Q4 2024, an estimated $9.52M.
  • Longbow Finance first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • Longbow Finance's Merck position peaked at $29.3M in Q2 2023.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Longbow Finance's 13F filing for Q4 2024, filed 4 Feb 2025.